The invention relates to substituted spirocyclic cyclohexane derivatives which have an affinity for the μ opioid receptor and the ORL1 receptor, processes for the preparation thereof, medicaments containing these compounds and the use of these compounds for the preparation of medicaments.
PYRROLOPYRIDAZINE JAK3 INHIBITORS AND THEIR USE FOR THE TREATMENT OF INFLAMMATORY AND AUTOIMMUNE DISEASES
申请人:Wrobleski Stephen T.
公开号:US20140011800A1
公开(公告)日:2014-01-09
The present invention provides compounds of formula I and pharmaceutically acceptable salts thereof. The formula I compounds inhibit tyrosine kinase activity of JAK3, thereby making them useful for the treatment of inflammatory and autoimmune diseases.
Provided are compounds of Formula I, or pharmaceutically acceptable salts thereof, and methods for their use and production.
本文提供了式 I 化合物或其药学上可接受的盐类,以及使用和生产它们的方法。
US8987268B2
申请人:——
公开号:US8987268B2
公开(公告)日:2015-03-24
Synthesis of Thermally Stable Acylamino-Substituted Bicyclic Dioxetanes and Their Base-Induced Chemiluminescent Decomposition
作者:Nobuko Watanabe、Yusuke Sano、Haruna Suzuki、Masatoshi Tanimura、Hisako K. Ijuin、Masakatsu Matsumoto
DOI:10.1021/jo101114b
日期:2010.9.3
charge-transfer-induced decomposition (CTID) to emit yellow−orange light. The chemiluminescence efficiencies ΦCL for dioxetanes 2 ranged from 10−6 to 10−2. On the other hand, dioxetane 4 bearing a 4-(benzothiazol-2-yl)-3-hydroxyphenyl moiety showed chemiluminescent decomposition with high efficiency (ΦCL = 0.15) comparable to its oxy-analogue 26. Prominent characteristics for CTID of the present dioxetanes were that